CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Genentech, Inc.
Target Audience: The intended audience for the activities is rheumatologists and other health care professionals involved in the treatment of patients with rheumatoid arthritis (RA).
Learning Objectives: Upon successful completion of this educational activity, participants should be better able to:
- Apply evidence-based approaches when selecting initial therapies for patients with RA.
- Optimize treatment approaches for patients with RA who do not respond adequately to anti-TNF agents.
- Employ personalized treatment regimens for patients with RA in scenarios where the use of methotrexate (MTX) is contraindicated or ineffective.
Activity Chair:
Eric M. Ruderman, MD
Professor of Medicine
Division of Rheumatology
Northwestern University Feinberg School of Medicine
Chicago, IL
Faculty:
Leonard H. Calabrese, DO
Professor of Medicine, Cleveland Clinic Lerner
College of Medicine of Case Western Reserve University
RJ Fasenmyer Chair of Clinical Immunology
Theodore F Classen D.O. Chair of Osteopathic Research and Education
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Cleveland, OH
Stanley B. Cohen, MD
Clinical Professor, Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director, Division of Rheumatology, Presbyterian Hospital—Dallas
Co-Medical Director, Metroplex Clinical Research Center
Dallas, TX
Jeffrey Curtis, MD, MS, MPH
University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology
William J. Koopman Endowed Professor in Rheumatology and Immunology
Director, UAB Arthritis Clinical Intervention Program
Co-Director, UABCenter for Education and Research on Therapeutics (CERTS)
Co-Director, UAB PharmacoEpidemiology and Economic Research (PEER) Group
Birmingham, AL
Reviewers:
Kevin Deane, MD
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification reviews on 8/31/2017 and 9/10/2018)
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material was originally approved for 1 year from the date of original release, October 13, 2015 to October 12, 2016. It has since been recertified for three additional years and will now expire on September 10, 2019.
How to Participate in This Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME Content, complete the CME posttest, and the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Faculty reports the following relationship(s) which are accurate at the time of original content release (October 13, 2015):
Eric M. Ruderman, MD
Consulting Fee: AbbVie, Amgen, Celgene, Janssen, Lilly, Medac, Novartis, Pfizer, Pharmacyclics, Vertex
Fees for Non-CE Services Received Directly From a Commercial Interest or its Agents: AbbVie
Contracted Research: AbbVie, Amgen, Pfizer, Pharmacyclics
Leonard H. Calabrese, DO
Consulting Fee: GSK, Janssen, Pfizer, Sanofi
Speakers Bureau: AbbVie, BMS, Crescendo, Genentech, Janssen
Stanley B. Cohen, MD
No relevant financial relationships to disclose.
Jeffrey Curtis, MD, MS, MPH
Consulting Fee: AbbVie, Amgen, BMS, Corrona, Crescendo, Genentech/Roche, Janssen, Pfizer, UCB
Reviewers report the following relationship(s):
Kevin Deane, MD
No relevant financial relationships to disclose.
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2015 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com